Clinical Trials in Minneapolis

Showing 2461-2480 of 6,957 trials

Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV)

NCT02829606

A device has been developed that has eye trackers integrated within the Head Mounted Display (HMD) and can remap text and images around the scotoma in real time to prevent information loss from a central scotoma. It can also carry out other types of image processing such as contrast enhancement and image magnification. The aim of this study is to assess the efficacy of this device on the visual performance of participants suffering from central vision loss, with and without remapping

Age-related Macular Degeneration

University of Minnesota8 participantsStarted Apr 2016

Minneapolis, Minnesota, United States

COMPLETEDNA< 1 mile

Journaling and Addiction Recovery: Piloting "Positive Recovery Journaling"

NCT04458181

The main objective of this study is to pilot test the Positive Peer Journaling (PPJ) \[later renamed "Positive Recovery Journaling" (PRJ)\] intervention and its feasibility and acceptability. A second objective is to compare individuals assigned to PPJ to individuals in a treatment as usual control group.

Addiction

University of Minnesota81 participantsStarted Jul 2020

Minneapolis, Minnesota, United States

TERMINATEDPhase 2< 1 mile

Open-Label Study of Oral Treprostinil in Digital Ulcers

NCT00848107

This open label extension trial will allow ongoing treatment of subjects who participated in the randomized controlled trials, and will provide long term information about the safety of treprostinil diethanolamine SR in subjects with SSc and digital ulcers.

Systemic Sclerosis

United Therapeutics115 participantsStarted Sep 2009

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Los Angeles, California, United States +23 more locations

Head Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV)

Journaling and Addiction Recovery: Piloting "Positive Recovery Journaling"

Open-Label Study of Oral Treprostinil in Digital Ulcers

Find Trials by Condition in Minneapolis

Improving Veteran Adherence to Treatment for PTSD Through Partnering With Families

Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic Dermatitis

Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis

A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat

A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma

Study of TPX-0046, A RET/SRC Inhibitor in Adult Subjects With Advanced Solid Tumors Harboring RET Fusions or Mutations

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)

Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)

Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

A Study of Replagal in Treatment-naïve Adults With Fabry Disease

Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies